Kyongbo Pharmaceutical Co Ltd
KRX:214390

Watchlist Manager
Kyongbo Pharmaceutical Co Ltd Logo
Kyongbo Pharmaceutical Co Ltd
KRX:214390
Watchlist
Price: 5 770 KRW 0.52% Market Closed
Market Cap: 138B KRW

Intrinsic Value

The intrinsic value of one Kyongbo Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 5 770 KRW, Kyongbo Pharmaceutical Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Kyongbo Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Kyongbo Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Kyongbo Pharmaceutical Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Kyongbo Pharmaceutical Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Kyongbo Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Kyongbo Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Kyongbo Pharmaceutical Co Ltd.

Explain Valuation
Compare Kyongbo Pharmaceutical Co Ltd to

Fundamental Analysis

Kyongbo Pharmaceutical Co Ltd
Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about Kyongbo Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kyongbo Pharmaceutical Co Ltd

Current Assets 160.9B
Cash & Short-Term Investments 2.6B
Receivables 58B
Other Current Assets 100.3B
Non-Current Assets 151.5B
Long-Term Investments 10.8B
PP&E 118.7B
Intangibles 4.2B
Other Non-Current Assets 17.8B
Current Liabilities 165.3B
Accounts Payable 17.1B
Accrued Liabilities 2.9B
Short-Term Debt 110.1B
Other Current Liabilities 35.1B
Non-Current Liabilities 5.1B
Long-Term Debt 1.5B
Other Non-Current Liabilities 3.5B
Efficiency

Free Cash Flow Analysis
Kyongbo Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Kyongbo Pharmaceutical Co Ltd

Revenue
243.4B KRW
Cost of Revenue
-151.1B KRW
Gross Profit
92.4B KRW
Operating Expenses
-83.7B KRW
Operating Income
8.7B KRW
Other Expenses
-8.3B KRW
Net Income
404.1m KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Kyongbo Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
ROIC is Increasing
Gross Margin is Increasing
Sustainable 3Y Average Gross Margin
hidden
Profitability
Score

Kyongbo Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Kyongbo Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Average Altman Z-Score
hidden
Solvency
Score

Kyongbo Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Kyongbo Pharmaceutical Co Ltd

There are no price targets for Kyongbo Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Kyongbo Pharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Kyongbo Pharmaceutical Co Ltd stock?

The intrinsic value of one Kyongbo Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW.

Is Kyongbo Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 5 770 KRW, Kyongbo Pharmaceutical Co Ltd is hidden .

Back to Top